EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases
Tarih
2014Yazar
Gundogdu, Ahmet Gokhan
Firat, Pinar
DOĞAN, RIZA
Onder, Sevgen
Üst veri
Tüm öğe kaydını gösterÖzet
Background: The impacts of epidermal growth factor receptor (EGFR) immunoexpression and RAS immunoexpression on the survival and prognosis of lung adenocarcinoma patients are debated in the literature.
Bağlantı
http://hdl.handle.net/20.500.12627/45866https://doi.org/10.3978/j.issn.2072-1439.2014.04.35
Koleksiyonlar
- Makale [92796]